Ingredient in common kitchen spice turmeric when combined with anti-nausea medication thalidomide effectively kills cancer cells
In a laboratory, preclinical study recently published by the journal Organic & Biomolecular Chemistry, Virginia Commonwealth University Massey Cancer Center researchers combined structural features from anti-nausea drug thalidomide with common kitchen spice turmeric to create hybrid molecules that effectively kill multiple myeloma cells. Scientists found that compounds 5 and 7 exhibited superior cell toxicity compared to curcumin alone or the combination of curcumin and thalidomide. Furthermore, the compounds were found to induce significant multiple myeloma cell death.
Courage in the face of cancer
Blog by Donna Highfill, writer, coach, humorist and change consultant. Originally published on The Huffington Post on August 17, 2013; reprinted with the author’s permission.
Massey and VCU Community Memorial Hospital open Southern Virginia’s first radiation treatment center
Community citizens, healthcare leaders, local politicians and officials gathered at VCU Community Memorial Hospital (VCU CMH) on August 14 for the official grand opening celebration of the Solari Radiation Therapy Center, the first and only radiation therapy center in the Southern Virginia Area. The center is a joint venture between VCU CMH and VCU Massey Cancer Center, who together provide VCU CMH’s Cancer and Specialty Care.
“Beat the heat” tips for cancer patients
With Virginia and other parts of the nation experiencing a summer heat wave, it is important for cancer patients to take the necessary precautions to protect themselves. Here are some tips to help keep yourself or your loved one cool this summer: limit sun exposure, use sunscreen, cover up...
New protein discovered with vast potential for treatment of cancer and other diseases
In cancer research, discovering a new protein that plays a role in cancer is like finding a key and a treasure map: follow the clues and eventually there could be a big reward. At least that’s the hope from a new study published in the journal Nature that discovered a novel protein called ceramide-1 phosphate transport protein (CPTP) – a finding that could eventually lead to the development of new drugs to treat a variety of cancers and other conditions involving inflammation and thrombosis, or blood clotting.